Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trialHuabin Hu, Yanhong Deng, Liang Kang et al.|The Lancet. Gastroenterology & hepatology|2021Cited by 304
<p>m<sup>6</sup>A methyltransferase METTL3 suppresses colorectal cancer proliferation and migration through p38/ERK pathways</p>Ru Deng, Yanhong Deng, Yi‐Kan Cheng et al.|OncoTargets and Therapy|2019Cited by 164
Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL TrialHuabin Hu, Yanhong Deng, Liang Kang et al.|Journal of Clinical Oncology|2024Cited by 76
Complete response in patients with locally advanced rectal cancer after neoadjuvant treatment with nivolumabJianwei Zhang, Hui Wang, Jian Cai et al.|OncoImmunology|2019Cited by 61
Modified FOLFOXIRI With or Without Cetuximab as Conversion Therapy in Patients with <i>RAS</i>/<i>BRAF</i> Wild-Type Unresectable Liver Metastases Colorectal Cancer: The FOCULM Multicenter Phase II TrialHuabin Hu, Yanhong Deng, Kun Wang et al.|The Oncologist|2020Cited by 50